Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NCCN Asia Consensus Statement prostate cancer.
Hinotsu S, Namiki M, Ozono S, Akaza H. Hinotsu S, et al. Among authors: ozono s. Jpn J Clin Oncol. 2018 Nov 1;48(11):964-965. doi: 10.1093/jjco/hyy116. Jpn J Clin Oncol. 2018. PMID: 30184146 Review.
A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (JPN-201 study).
Matsubara N, Uemura H, Satoh T, Suzuki H, Nishiyama T, Uemura H, Hashine K, Imanaka K, Ozono S, Akaza H. Matsubara N, et al. Among authors: ozono s. Jpn J Clin Oncol. 2014 Dec;44(12):1216-26. doi: 10.1093/jjco/hyu149. Epub 2014 Oct 15. Jpn J Clin Oncol. 2014. PMID: 25320340 Free PMC article. Clinical Trial.
A phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapy.
Satoh T, Uemura H, Tanabe K, Nishiyama T, Terai A, Yokomizo A, Nakatani T, Imanaka K, Ozono S, Akaza H. Satoh T, et al. Among authors: ozono s. Jpn J Clin Oncol. 2014 Dec;44(12):1206-15. doi: 10.1093/jjco/hyu148. Epub 2014 Oct 1. Jpn J Clin Oncol. 2014. PMID: 25425730 Free PMC article. Clinical Trial.
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial.
Oyama M, Sugiyama T, Nozawa M, Fujimoto K, Kishida T, Kimura G, Tokuda N, Hinotsu S, Shimozuma K, Akaza H, Ozono S. Oyama M, et al. Among authors: ozono s. Jpn J Clin Oncol. 2017 Jun 1;47(6):551-559. doi: 10.1093/jjco/hyw194. Jpn J Clin Oncol. 2017. PMID: 28334974 Free PMC article. Clinical Trial.
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan.
Nishimura K, Nonomura N, Hashine K, Kanayama HO, Ozono S, Miura T, Miki T, Kakehi Y, Arai Y, Ogawa O, Fujita R, Nonomura K, Mizokami A, Hoshi S, Akaza H. Nishimura K, et al. Among authors: ozono s. Int J Clin Oncol. 2013 Apr;18(2):306-13. doi: 10.1007/s10147-012-0380-1. Epub 2012 Feb 21. Int J Clin Oncol. 2013. PMID: 22350099 Clinical Trial.
435 results